News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
246 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (119)
3 (12)
4 (242)
5 (269)
6 (241)
7 (243)
8 (78)
9 (2)
10 (3)
11 (232)
12 (312)
13 (213)
14 (243)
15 (110)
16 (8)
17 (9)
18 (85)
19 (267)
20 (246)
21 (243)
22 (113)
23 (7)
24 (12)
25 (220)
26 (276)
27 (239)
28 (312)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Business
Cold Rescue Elements the Perfect Antidote to the Winter Cold Season
The cold season, which begins in late August and continues until March or April, may be due to schools opening, the colder weather or just because people spend more time indoors.
February 20, 2019
·
2 min read
Deals
Weekend Unlimited Completes Acquisition Of Jamaican Assets
With Tier-3 Cultivator’s Licence, Jamaican tourism and export markets to be active in Q2, 2019
February 20, 2019
·
4 min read
Drug Development
Phase 1 Data Published in Nature Communications Show Potential of mRNA Encoding VEGF-A as a Regenerative Therapeutic
AZD8601 now in an ongoing Phase 2a study with patients receiving epicardial injections of VEGF-A mRNA during coronary artery bypass grafting surgery
February 20, 2019
·
7 min read
Drug Development
DelMar Pharmaceuticals Achieves Halfway Enrollment Point for Phase 2 Clinical Trial of VAL-083 in Newly Diagnosed MGMT-unmethylated GBM
Complete Response Rate of 42% as Assessed by Principal Investigator Supports VAL-082’s Activity in GBM
February 20, 2019
·
8 min read
Deals
Advantia Health Expands Nationally With Acquisition of Heartland Women’s Healthcare
Rapidly growing Advantia Health adds 25 locations, 50 providers and 180,000 patients across Missouri and southern Illinois
February 20, 2019
·
4 min read
Biotech Bay
Berkeley Lights Selected as One of the World’s Most Innovative Companies of 2019 by Fast Company
Berkeley Lights, Inc., a leader in digital cell biology, announced that it has been named one of Fast Company’s 2019 Most Innovative Companies in Biotech.
February 20, 2019
·
3 min read
FDA
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) Monotherapy for Third-Line Treatment of Patients with Advanced Small Cell Lung Cancer (SCLC)
Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) for KEYTRUDA
February 20, 2019
·
28 min read
Business
Aurora Cannabis Announces Key Changes to its Board of Directors
Aurora Cannabis Inc. announced that Michael Singer, previously Chairman of the Board, has been appointed Executive Chairman of the Board of Directors.
February 20, 2019
·
7 min read
Pharm Country
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease
Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol
February 20, 2019
·
10 min read
Deals
Clearlake Capital-Backed symplr To Acquire API Healthcare
Strategic acquisition creates the healthcare industry’s only large-scale provider of governance, risk and compliance and human capital management software solutions
February 20, 2019
·
4 min read
Previous
4 of 25
Next